Seal, Stopping Eczema and Allergy Study

Inclusion Criteria:

   1. Participants who develop early onset visible dry skin or atopic dermatitis up to and
   equal to 12 weeks of age.

   2. Stated willingness to comply with all study procedures and availability for the
   duration of the study

   3. In good general health as evidenced by medical history

   4. No known adverse reaction to any of the study medications, their components or
   excipients

Exclusion Criteria:

   1. Infants <3kg body weight

   2. Infants with a chronic disease requiring therapy (e.g. heart disease, diabetes,
   serious neurological defects, immunodeficiency)

   3. Known moderate to severe cutaneous skin disorder other than AD, including but not
   limited to cutaneous mastocytosis, bullous skin disease, pustular skin disease,
   neonatal HSV, aplasia, and albinism

   4. Parents or guardians unwilling to sign consent

   5. Current participant or participation since birth in any interventional study

   6. Investigator or designee considers that the participant or parent/guardian would be
   unsuitable for inclusion in the study (for ex/ long stay in NICU)

   7. A course of antibiotics in infant within 7 days of enrollment

   8. Any known food allergies